Investor forum....Now if we could only get invited to this type of forum.....
Then again....
Perhaps we have and got no luck!
ADVANCED PROTEOME THERAPEUTICS ("APC-V")
- Selected To Participate In The Life Sciences US/Canada
- Venture Capital Pipeline
Advanced Proteome Therapeutics (the Corporation or APC) is pleased to
announce that it has been selected to participate in the upcoming Life
Sciences US/Canada Venture Capital Pipeline to be held on Thursday, May 13,
2010. The Corporation will present an overview of its platform technologies
and progress to date in applications of its Swift LinkageTM Technologies
and advancing protein conjugates in development to clinical status.
The US/Canada Venture Capital Pipeline links venture capital firms
(VCs) and investment banking firms based in the U.S. with Canadian
companies seeking financing. The focus of the Pipeline event this year will
be Life Sciences.
The first Pipeline was held in June 2002 and 16 more events have
occurred since that date. The event is designed to build relationships and
create business opportunities between U.S. investors and Canadian
companies. This May, multiple pre-screened Canadian Life Sciences companies
will come to Boston to meet one-on-one with U.S. investors.
Since 2002, Burns & Levinson Canada Co. and Burns & Levinson LLP have
hosted Pipeline events that focus on linking venture capital firms based in
the U.S. with Canadian health and technology companies seeking financing.
By planning and facilitating one-on-one meetings, this one-day event
promotes building strategic relationships and forging lasting alliances.
The Pipeline is hosted three to four times a year at the firm's Boston, MA
office and includes additional networking opportunities during the
breakfast presentation and cocktail reception in the evening. In February
2007, this event became a co-branded partnership with Burns & Levinson LLP
and PricewaterhouseCoopers (Canada).